Status:
COMPLETED
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection
Lead Sponsor:
Osaka General Medical Center
Conditions:
Emergent Coronary Procedure
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
This study is to investigate the effect of Sodium Bicarbonate bolus injection in patients undergoing an emergent coronary procedure for prevention of contrast-induced nephropathy.
Detailed Description
This study is to investigate the effect of Sodium Bicarbonate bolus injection in patients undergoing an emergent coronary procedure for prevention of contrast-induced nephropathy.The End point is deve...
Eligibility Criteria
Inclusion
- Patients undergoing an emergent coronary procedure(within 60 minutes from admission)
Exclusion
- On dialysis
- Pregnancy
- Past use of bicarbonate or N-Acetyl-Cystein in 48hr
- Past exposure to contrast media in 48hr
- Circulatory insufficiency with lactic acidosis.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00700375
Start Date
July 1 2008
End Date
March 1 2010
Last Update
July 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osaka General Medical Center
Osaka, Japan, 558-8558